Global and China Liquid Biopsy Industry

Global and China Liquid Biopsy Industry Ecological Development and Analysis Report 2024

Global and China Liquid Biopsy Industry

Global and China Liquid Biopsy Industry Ecological Development and Analysis Report 2024

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

In terms of market side, this report researches the Liquid Biopsy revenue, growth rate, market share by manufacturers, by type, by application and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

The global Liquid Biopsy market size in 2023 is 4710.0 million US dollars, and it is expected to be 14738.6 million US dollars by 2030, with a compound annual growth rate of 17.70% expected in 2024-2030.

MARKET COMPETITIVE LANDSCAPE:

The main players in the Liquid Biopsy market include Bio-Rad Laboratories (U.S.), Biocept Inc. (U.S.), Guardant Health (U.S.), Illumina Inc. (U.S.), and F. Hoffmann-La Roche Ltd. (Switzerland). The share of the top 3 players in the Liquid Biopsy market is XX%.

REGION SHARE:

The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Liquid Biopsy market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:

The report segments the market by Type and Application. Assay Kits accounted for XX% of Liquid Biopsy market in 2023. Instruments share of XX%.

Circulating Tumor Cells accounted for XX% of the Liquid Biopsy market in 2023. Circulating Tumor DNA (ctDNA) accounts for XX%.

Report Includes:

This report presents an overview of global market for Liquid Biopsy. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key players of Liquid Biopsy, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Liquid Biopsy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liquid Biopsy market share and industry ranking of main players, data from 2019 to 2024. Identification of the major stakeholders in the global Liquid Biopsy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, from 2019 to 2030. Evaluation and forecast the market size for Liquid Biopsy sales, projected growth trends, technology, application and end-user industry.

Chapter Outline

Chapter 1: Introduces the product overview, research purposes, and then includes economic analysis of global regions, inflation analysis, and the impact of the Russian-Ukrainian war on the market.

Chapter 2: Analysis of the competitive environment of Liquid Biopsy market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the players' M&A and expansion in recent years.

Chapters 3-5: Segmented the global Liquid Biopsy market by type, application and region. Analyze the revenue, sales and price of market segments from different perspectives.

Chapter 6: Analyzes the main companies in the Liquid Biopsy industry, including their main businesses, products/services, sales, prices, revenue, gross margin, and SWOT Analysis.

Chapter 7: Analyzes the Liquid Biopsy manufacturing cost, including raw material analysis, manufacturing cost structure, and industrial chain.

Chapter 8: Analyzes the Liquid Biopsy industry chain, including marketing channels, distributors and major downstream buyers.

Chapter 9: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.

Chapters 10-11: Provide detailed Liquid Biopsy market forecast data, broken down by type, application, and region to help understand future growth trends.

Chapter 12: The main points and conclusions of the report.

Highlights-Regions

North America

United States

Canada

China

Asia Pacific (Excluding China)

Japan

Korea

Southeast Asia

India

Australia

EMEA

Europe

Germany

France

UK

Italy

Russia

Nordic

Middle East

Africa

Latin America

Brazil

Argentina

Mexico

Player list

Bio-Rad Laboratories (U.S.)

Biocept Inc. (U.S.)

Guardant Health (U.S.)

Illumina Inc. (U.S.)

F. Hoffmann-La Roche Ltd. (Switzerland)

Johnson & Johnson (U.S.)

Laboratory Corporation of America Holdings (U.S.)

MDxHealth SA (Belgium)

QIAGEN N.V. (Germany)

Thermo Fisher Scientific Inc. (U.S.)

Types list

Assay Kits

Instruments

Services

Application list

Circulating Tumor Cells

Circulating Tumor DNA (ctDNA)

Cell-free DNA (cfDNA)

Extracellular Vesicles (EVS)

Other Circulating Biomarkers

Table of Content

1 Liquid Biopsy Market Introduction and Overview

1.1 Liquid Biopsy Definition

1.2 Research Purposes

1.3 Currency Rate

1.4 Report Timeline

1.5 Economic Analysis of Global Regions

1.6 Inflation Analysis

1.7 The Impact of the Russian-Ukrainian War on the Market

2 Market Competition by Manufacturers

2.1 Global Liquid Biopsy Sales and Market Share by Manufacturer

2.2 Global Liquid Biopsy Revenue and Market Share by Manufacturer

2.3 Global Liquid Biopsy Average Price by Manufacturers

2.4 Manufacturers Liquid Biopsy Production Sites, Area Served, Product Types

2.5 Liquid Biopsy Market Competitive Situation and Trends

2.5.1 Liquid Biopsy Market Concentration Rate

2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2024

2.5.3 Mergers & Acquisitions, Expansion

3 Global Liquid Biopsy Historical Market Analysis by Type

3.1 Market Size Analysis by Types

3.1.4 Global Liquid Biopsy Market Share by Type 2019 VS 2023

3.2 Global Liquid Biopsy Revenue and Market Share by Type

3.3 Global Liquid Biopsy Sales and Market Share by Type

4 Global Liquid Biopsy Historical and Forecast Market Analysis by Application

4.1 Market Size Analysis by Application

4.1.4 Global Liquid Biopsy Market Share by Application 2019 VS 2023

4.2 Global Liquid Biopsy Revenue Market Share by Application (2019-2024)

4.3 Global Liquid Biopsy Sales Market Share by Application (2019-2024)

5 Global Market Growth Trends Analysis

5.1 Global Liquid Biopsy Market Size (2019-2024)

5.2 Liquid Biopsy Growth Trends Analysis by Regions

5.2.1 Liquid Biopsy Market Size by Regions: 2019 VS 2024 VS 2030

5.2.2 Liquid Biopsy Historic Revenue Market Size by Regions (2019-2024)

5.2.3 Liquid Biopsy Historic Sales Market Size by Regions (2019-2024)

5.3 North America

5.3.1 North America Liquid Biopsy Revenue by Countries (2019-2024)

5.3.2 North America Liquid Biopsy Sales by Countries (2019-2024)

5.3.3 North America SWOT Analysis

5.3.4 United States

5.3.5 Canada

5.4 China

5.4.1 China SWOT Analysis

5.5 Asia Pacific (Excluding China)

5.5.1 Asia Pacific Liquid Biopsy Revenue by Countries (2019-2024)

5.5.2 Asia Pacific Liquid Biopsy Sales by Countries (2019-2024)

5.5.3 Asia Pacific SWOT Analysis

5.5.4 Japan

5.5.5 Korea

5.5.6 Southeast Asia

5.5.7 India

5.5.8 Australia

5.6 EMEA

5.6.1 EMEA Liquid Biopsy Revenue by Countries (2019-2024)

5.6.2 EMEA Liquid Biopsy Sales by Countries (2019-2024)

5.6.3 EMEA SWOT Analysis

5.6.4 Europe

5.6.5 Middle East

5.6.6 Africa

5.7 Latin America

5.7.1 Latin America Liquid Biopsy Revenue by Countries (2019-2024)

5.7.2 Latin America Liquid Biopsy Sales by Countries (2019-2024)

5.7.3 Latin America SWOT Analysis

5.7.4 Brazil

5.7.5 Argentina

5.7.6 Mexico

6 Players Profiles

6.1 Bio-Rad Laboratories (U.S.)

6.1.1 Bio-Rad Laboratories (U.S.) Company Profile

6.1.2 Liquid Biopsy Product Overview

6.1.3 Bio-Rad Laboratories (U.S.) Liquid Biopsy Market Performance (2019-2024)

6.1.4 Bio-Rad Laboratories (U.S.) Business Overview

6.1.5 SWOT Analysis

6.2 Biocept Inc. (U.S.)

6.2.1 Biocept Inc. (U.S.) Company Profile

6.2.2 Liquid Biopsy Product Overview

6.2.3 Biocept Inc. (U.S.) Liquid Biopsy Market Performance (2019-2024)

6.2.4 Biocept Inc. (U.S.) Business Overview

6.2.5 SWOT Analysis

6.3 Guardant Health (U.S.)

6.3.1 Guardant Health (U.S.) Company Profile

6.3.2 Liquid Biopsy Product Overview

6.3.3 Guardant Health (U.S.) Liquid Biopsy Market Performance (2019-2024)

6.3.4 Guardant Health (U.S.) Business Overview

6.3.5 SWOT Analysis

6.4 Illumina Inc. (U.S.)

6.4.1 Illumina Inc. (U.S.) Company Profile

6.4.2 Liquid Biopsy Product Overview

6.4.3 Illumina Inc. (U.S.) Liquid Biopsy Market Performance (2019-2024)

6.4.4 Illumina Inc. (U.S.) Business Overview

6.4.5 SWOT Analysis

6.5 F. Hoffmann-La Roche Ltd. (Switzerland)

6.5.1 F. Hoffmann-La Roche Ltd. (Switzerland) Company Profile

6.5.2 Liquid Biopsy Product Overview

6.5.3 F. Hoffmann-La Roche Ltd. (Switzerland) Liquid Biopsy Market Performance (2019-2024)

6.5.4 F. Hoffmann-La Roche Ltd. (Switzerland) Business Overview

6.5.5 SWOT Analysis

6.6 Johnson & Johnson (U.S.)

6.6.1 Johnson & Johnson (U.S.) Company Profile

6.6.2 Liquid Biopsy Product Overview

6.6.3 Johnson & Johnson (U.S.) Liquid Biopsy Market Performance (2019-2024)

6.6.4 Johnson & Johnson (U.S.) Business Overview

6.6.5 SWOT Analysis

6.7 Laboratory Corporation of America Holdings (U.S.)

6.7.1 Laboratory Corporation of America Holdings (U.S.) Company Profile

6.7.2 Liquid Biopsy Product Overview

6.7.3 Laboratory Corporation of America Holdings (U.S.) Liquid Biopsy Market Performance (2019-2024)

6.7.4 Laboratory Corporation of America Holdings (U.S.) Business Overview

6.7.5 SWOT Analysis

6.8 MDxHealth SA (Belgium)

6.8.1 MDxHealth SA (Belgium) Company Profile

6.8.2 Liquid Biopsy Product Overview

6.8.3 MDxHealth SA (Belgium) Liquid Biopsy Market Performance (2019-2024)

6.8.4 MDxHealth SA (Belgium) Business Overview

6.8.5 SWOT Analysis

6.9 QIAGEN N.V. (Germany)

6.9.1 QIAGEN N.V. (Germany) Company Profile

6.9.2 Liquid Biopsy Product Overview

6.9.3 QIAGEN N.V. (Germany) Liquid Biopsy Market Performance (2019-2024)

6.9.4 QIAGEN N.V. (Germany) Business Overview

6.9.5 SWOT Analysis

6.10 Thermo Fisher Scientific Inc. (U.S.)

6.10.1 Thermo Fisher Scientific Inc. (U.S.) Company Profile

6.10.2 Liquid Biopsy Product Overview

6.10.3 Thermo Fisher Scientific Inc. (U.S.) Liquid Biopsy Market Performance (2019-2024)

6.10.4 Thermo Fisher Scientific Inc. (U.S.) Business Overview

6.10.5 SWOT Analysis

7 Liquid Biopsy Manufacturing Cost Analysis

7.1 Liquid Biopsy Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Liquid Biopsy

7.4 Liquid Biopsy Industrial Chain Analysis

8 Market Channel, Distributors, Traders and Dealers

8.1 Market Channel Status

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.2 Liquid Biopsy Typical Distributors

8.3 Liquid Biopsy Typical Customers

9 Liquid Biopsy Industry Dynamic Analysis

9.1 Liquid Biopsy Market Trends Analysis

9.2 Liquid Biopsy Market Drivers Analysis

9.3 Liquid Biopsy Market Challenges Analysis

9.4 Liquid Biopsy Market Restraints Analysis

10 Global Liquid Biopsy Forecast Market Analysis by Type & Application

10.1 Global Liquid Biopsy Revenue Market Forecast by Type (2024-2030)

10.2 Global Liquid Biopsy Sales Market Forecast by Type (2024-2030)

10.3 Liquid Biopsy Revenue Market Forecast by Application (2024-2030)

10.4 Liquid Biopsy Sales Market Forecast by Application (2024-2030)

11 Global Liquid Biopsy Forecast Market Analysis by Region

11.1 Liquid Biopsy Revenue Market Forecast by Region (2024-2030)

11.2 Liquid Biopsy Sales Market Forecast by Region (2024-2030)

11.3 North America Liquid Biopsy Forecast Market Analysis

11.4 EMEA Liquid Biopsy Forecast Market Analysis

11.5 China Liquid Biopsy Forecast Market Analysis

11.6 Asia-Pacific Liquid Biopsy Forecast Market Analysis

11.7 Latin America Liquid Biopsy Forecast Market Analysis

12 Research Findings and Conclusion

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Global and China Liquid Biopsy Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
How are players chosen for the research coverage of the Global and China Liquid Biopsy Market study?
MI used a variety of industry standards such as NAICS, ICB, TRIC, and others to identify functional players in the industry, which they then shortlist and validate in an iterative process to finalize the most relevant players.
What are the major applications for Global and China Liquid Biopsy?
Global and China Liquid Biopsy has a wide range of applications, including and others.
What is the anticipated growth rate for the Global and China Liquid Biopsy Market?
During the projected year from 2025 to 2030, the Global and China Liquid Biopsy Market is expected to grow at a CAGR of xx%.
What challenges does the Global and China Liquid Biopsy Market face in the future?
The convergence of various vital triggers, including a major slowdown in Western economies, and some critical points in globalization, leads to the transformation of business in the Global and China Liquid Biopsy Market across the extensive corporate landscape.
What is the estimated global market value of the Global and China Liquid Biopsy Market?
The Global and China Liquid Biopsy Market is expected to reach a considerable market valuation.